All Stories

  1. Reporting of D-dimer data in COVID-19: some confusion and potential for misinformation

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), May 2020, De Gruyter

    Dr Emmanuel J Favaloro

  2. Mixing studies for lupus anticoagulant: mostly yes, sometimes no

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), March 2020, De Gruyter

    Dr Emmanuel J Favaloro

  3. Laboratory testing for activated protein C resistance: rivaroxaban induced interference and a comparative evaluation of andexanet alfa and DOAC Stop to neutralise interference

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), March 2020, De Gruyter

    Dr Emmanuel J Favaloro

  4. Danger of false negative (exclusion) or false positive (diagnosis) for ‘congenital thrombophilia’ in the age of anticoagulants

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), November 2018, De Gruyter

    Dr Emmanuel J Favaloro

  5. Recent initiatives in harmonization of hemostasis practice

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), May 2018, De Gruyter

    Dr Emmanuel J Favaloro

  6. On the complexity of hemostasis and the need for harmonization of test practice

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), May 2018, De Gruyter

    Dr Emmanuel J Favaloro

  7. Towards harmonization of external quality assessment/proficiency testing in hemostasis

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), April 2018, De Gruyter

    Dr Emmanuel J Favaloro

  8. Utility of the von Willebrand factor collagen binding assay in the diagnosis of von Willebrand disease

    Article • American Journal of Hematology, October 2016, Wiley

    Dr Emmanuel J Favaloro

  9. Type 2M and Type 2A von Willebrand Disease: Similar but Different

    Article • Seminars in Thrombosis and Hemostasis, May 2016, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  10. 2016 Eberhard F. Mammen Award Announcements: Part I — Most Popular Articles

    Article • Seminars in Thrombosis and Hemostasis, May 2016, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  11. Type 2M von Willebrand disease - more often misidentified than correctly identified

    Article • Haemophilia, March 2016, Wiley

    Dr Emmanuel J Favaloro

  12. Editorial Compilation I

    Article • Seminars in Thrombosis and Hemostasis, February 2016, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  13. Welcome to Seminars in Thrombosis & Hemostasis 2016: New (2014) Impact Factor and Most Highly Cited Articles

    Article • Seminars in Thrombosis and Hemostasis, February 2016, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  14. 2015 Eberhard F. Mammen Award Announcements: Part II—Young Investigator Awards

    Article • Seminars in Thrombosis and Hemostasis, November 2015, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  15. 2015 Eberhard F. Mammen Award Announcements: Part I—Most Popular Articles

    Article • Seminars in Thrombosis and Hemostasis, October 2015, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  16. “Bleeding in the jungle”

    Article • American Journal of Hematology, August 2015, Wiley

    Dr Emmanuel J Favaloro

  17. Hot Topics VII

    Article • Seminars in Thrombosis and Hemostasis, June 2015, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  18. The Platelet Function Analyser (PFA)-100 and von Willebrand disease: a story well over 16 years in the making

    Article • Haemophilia, May 2015, Wiley

    Dr Emmanuel J Favaloro

  19. Laboratory Testing in the Era of Direct or Non–Vitamin K Antagonist Oral Anticoagulants: A Practical Guide to Measuring Their Activity and Avoiding Diagnostic Errors

    Article • Seminars in Thrombosis and Hemostasis, February 2015, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  20. Welcome to Seminars in Thrombosis & Hemostasis 2015: New (2013) Impact Factor and Most Highly Cited Articles

    Article • Seminars in Thrombosis and Hemostasis, February 2015, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  21. The new and the old of heparin-induced thrombocytopenia

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2015, De Gruyter

    Dr Emmanuel J Favaloro

  22. Articles from Seminars in Thrombosis & Hemostasis (STH) Archives: Part II

    Article • Seminars in Thrombosis and Hemostasis, November 2014, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  23. A Short History of Thrombosis and Hemostasis: Part II (40th Year Celebratory Issue)

    Article • Seminars in Thrombosis and Hemostasis, November 2014, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  24. 2014 Eberhard F. Mammen Award Announcements: Part II—Young Investigator Awards

    Article • Seminars in Thrombosis and Hemostasis, October 2014, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  25. Aging Hemostasis: Changes to Laboratory Markers of Hemostasis As We Age—A Narrative Review

    Article • Seminars in Thrombosis and Hemostasis, August 2014, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  26. Evaluating errors in the laboratory identification of von Willebrand disease in the real world

    Article • Thrombosis Research, August 2014, Elsevier

    Dr Emmanuel J Favaloro

  27. Comparative sensitivity of commercially available aPTT reagents to mulga snake (Pseudechis australis) venom

    Article • Pathology, August 2014, Elsevier

    Dr Emmanuel J Favaloro

  28. A Short History of Thrombosis and Hemostasis: Part I (40th Year Celebratory Issue)

    Article • Seminars in Thrombosis and Hemostasis, July 2014, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  29. Articles from Seminars in Thrombosis & Hemostasis (STH) Archives

    Article • Seminars in Thrombosis and Hemostasis, July 2014, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  30. Diagnosing von Willebrand Disease: A Short History of Laboratory Milestones and Innovations, Plus Current Status, Challenges, and Solutions

    Article • Seminars in Thrombosis and Hemostasis, June 2014, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  31. Combined Administration of Antibiotics and Direct Oral Anticoagulants: A Renewed Indication for Laboratory Monitoring?

    Article • Seminars in Thrombosis and Hemostasis, June 2014, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  32. Response to “Comment on E-Cigarettes and Cardiovascular Risk: Beyond Science and Mysticism”

    Article • Seminars in Thrombosis and Hemostasis, May 2014, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  33. 2014 Eberhard F. Mammen Award Announcements: Part I—Most Popular Articles

    Article • Seminars in Thrombosis and Hemostasis, May 2014, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  34. Laboratory testing for factor inhibitors

    Article • Haemophilia, April 2014, Wiley

    Dr Emmanuel J Favaloro

  35. von Willebrand disease and platelet disorders

    Article • Haemophilia, April 2014, Wiley

    Dr Emmanuel J Favaloro

  36. Interference from heterophilic antibodies in D-dimer assessment. A case report

    Article • Blood Coagulation & Fibrinolysis, April 2014, Wolters Kluwer Health

    Dr Emmanuel J Favaloro

  37. Influence of centrifuge brake on residual platelet count and routine coagulation tests in citrated plasma

    Article • Blood Coagulation & Fibrinolysis, April 2014, Wolters Kluwer Health

    Dr Emmanuel J Favaloro

  38. Artefactual “in-vitro coagulopathy” in a patient with non-Hodgkin lymphoma and lower gastrointestinal bleeding

    Article • The Medical Journal of Australia, March 2014, Australasian Medical Publishing Co. Pty Ltd. (AMPCo)

    Dr Emmanuel J Favaloro

  39. Quality in Hemostasis and Thrombosis — Part III

    Article • Seminars in Thrombosis and Hemostasis, February 2014, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  40. Standardization and Harmonization of Antiphospholipid Antibody Assays

    Article • Seminars in Thrombosis and Hemostasis, February 2014, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  41. External Quality Assessment/Proficiency Testing and Internal Quality Control for the PFA-100 and PFA-200: An Update

    Article • Seminars in Thrombosis and Hemostasis, February 2014, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  42. A Tribute to Professor Jerry Koutts, MD (Syd), BS, FRACP, FRCPA (1944–2013)

    Article • Seminars in Thrombosis and Hemostasis, January 2014, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  43. Welcome to Seminars in Thrombosis & Hemostasis 2014

    Article • Seminars in Thrombosis and Hemostasis, January 2014, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  44. Hot Topics V

    Article • Seminars in Thrombosis and Hemostasis, January 2014, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  45. Technological Advances in the Hemostasis Laboratory

    Article • Seminars in Thrombosis and Hemostasis, January 2014, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  46. The futility of thrombophilia testing

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2014, De Gruyter

    Dr Emmanuel J Favaloro

  47. E-Cigarettes and Cardiovascular Risk: Beyond Science and Mysticism

    Article • Seminars in Thrombosis and Hemostasis, December 2013, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  48. Problems and Solutions in Laboratory Testing for Hemophilia

    Article • Seminars in Thrombosis and Hemostasis, November 2013, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  49. Editorial

    Article • Seminars in Thrombosis and Hemostasis, October 2013, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  50. Technical Evaluation of the Novel Preanalytical Module on Instrumentation Laboratory ACL TOP: Advancing Automation in Hemostasis Testing

    Article • SLAS TECHNOLOGY, October 2013, Elsevier

    Dr Emmanuel J Favaloro

  51. Problems and Solutions in Laboratory Testing for Hemophilia

    Article • Seminars in Thrombosis and Hemostasis, September 2013, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  52. Influence of Residual Platelet Count on Routine Coagulation, Factor VIII, and Factor IX Testing in Postfreeze-Thaw Samples

    Article • Seminars in Thrombosis and Hemostasis, September 2013, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  53. Sample collection and platelet function testing

    Article • Blood Coagulation & Fibrinolysis, September 2013, Wolters Kluwer Health

    Dr Emmanuel J Favaloro

  54. Lupus anticoagulant testing – sometimes mixing is required

    Article • Blood Coagulation & Fibrinolysis, September 2013, Wolters Kluwer Health

    Dr Emmanuel J Favaloro

  55. Still more discussion on the journal impact factor

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), August 2013, De Gruyter

    Dr Emmanuel J Favaloro

  56. 2013 Eberhard F. Mammen Award Announcements

    Article • Seminars in Thrombosis and Hemostasis, August 2013, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  57. Laboratory testing for the new oral anticoagulants: a review of current practice

    Article • Pathology, June 2013, Elsevier

    Dr Emmanuel J Favaloro

  58. Venous Thrombosis Associated with HMG-CoA Reductase Inhibitors

    Article • Seminars in Thrombosis and Hemostasis, April 2013, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  59. Variability and diagnostic utility of antiphospholipid antibodies including lupus anticoagulants

    Article • International Journal of Laboratory Hematology, April 2013, Wiley

    Dr Emmanuel J Favaloro

  60. Quality in Hemostasis and Thrombosis, Part II

    Article • Seminars in Thrombosis and Hemostasis, March 2013, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  61. Regulation in Hemostasis and Thrombosis: Part I—In Vitro Diagnostics

    Article • Seminars in Thrombosis and Hemostasis, March 2013, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  62. Laboratory Evaluation of Von Willebrand Disease: Phenotypic Analysis

    Article • February 2013, Wiley

    Dr Emmanuel J Favaloro

  63. Causes of Errors in Medical Laboratories

    Article • February 2013, Wiley

    Dr Emmanuel J Favaloro

  64. External Quality Assessment of Factor VIII Inhibitor Assays

    Article • Seminars in Thrombosis and Hemostasis, February 2013, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  65. Hot Topics IV

    Article • Seminars in Thrombosis and Hemostasis, February 2013, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  66. Trials and tribulations in lupus anticoagulant testing

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2013, De Gruyter

    Dr Emmanuel J Favaloro

  67. Article downloads and citations: Is there any relationship?

    Article • Clinica Chimica Acta, January 2013, Elsevier

    Dr Emmanuel J Favaloro

  68. Welcome to Seminars in Thrombosis & Hemostasis 2013

    Article • Seminars in Thrombosis and Hemostasis, December 2012, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  69. Interference in Coagulation Testing: Focus on Spurious Hemolysis, Icterus, and Lipemia

    Article • Seminars in Thrombosis and Hemostasis, December 2012, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  70. Time for a conceptual shift in assessment of internal quality control for whole blood or cell-based testing systems? An evaluation using platelet function and the PFA-100 as a case example

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), November 2012, De Gruyter

    Dr Emmanuel J Favaloro

  71. Massive Posttraumatic Bleeding: Epidemiology, Causes, Clinical Features, and Therapeutic Management

    Article • Seminars in Thrombosis and Hemostasis, October 2012, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  72. Novel and Emerging Therapies: Thrombus-Targeted Fibrinolysis

    Article • Seminars in Thrombosis and Hemostasis, October 2012, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  73. Quality in Hemostasis and Thrombosis—Part I

    Article • Seminars in Thrombosis and Hemostasis, September 2012, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  74. Discard tube for coagulation testing

    Article • Blood Coagulation & Fibrinolysis, September 2012, Wolters Kluwer Health

    Dr Emmanuel J Favaloro

  75. New developments in the diagnosis and treatment of von Willebrand disease

    Article • Clinical Investigation, August 2012, OMICS Publishing Group

    Dr Emmanuel J Favaloro

  76. ABO blood group, hypercoagulability, and cardiovascular and cancer risk

    Article • Critical Reviews in Clinical Laboratory Sciences, August 2012, Taylor & Francis

    Dr Emmanuel J Favaloro

  77. Laboratory hemostasis: milestones in Clinical Chemistry and Laboratory Medicine

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), July 2012, De Gruyter

    Dr Emmanuel J Favaloro

  78. In Vitro and In Vivo Hemolysis

    Article • July 2012, De Gruyter

    Dr Emmanuel J Favaloro

  79. Thrombotic and Hemorrhagic Syndromes Associated with Autoimmunity and Infection

    Article • Seminars in Thrombosis and Hemostasis, July 2012, Thieme Publishing Group

    ANTONIO COPPOLA, Dr Emmanuel J Favaloro

  80. 2012 Eberhard F. Mammen Award Announcements

    Article • Seminars in Thrombosis and Hemostasis, July 2012, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  81. External Quality Assurance for Heparin Monitoring

    Article • Seminars in Thrombosis and Hemostasis, June 2012, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  82. Acquired Inhibitors of Coagulation Factors: Part I—Acquired Hemophilia A

    Article • Seminars in Thrombosis and Hemostasis, June 2012, Thieme Publishing Group

    ANTONIO COPPOLA, Dr Emmanuel J Favaloro

  83. Acquired Inhibitors of Coagulation Factors: Part II

    Article • Seminars in Thrombosis and Hemostasis, June 2012, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  84. Acquired Functional Coagulation Inhibitors: Review on Epidemiology, Results of a Wet-Workshop on Laboratory Detection, and Implications for Quality of Inhibitor Diagnosis

    Article • Seminars in Thrombosis and Hemostasis, June 2012, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  85. Difficulties and pitfalls in the laboratory diagnosis of bleeding disorders

    Article • Haemophilia, June 2012, Wiley

    Dr Emmanuel J Favaloro

  86. Quality Standards for Sample Processing, Transportation, and Storage in Hemostasis Testing

    Article • Seminars in Thrombosis and Hemostasis, June 2012, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  87. Quality Standards for Sample Collection in Coagulation Testing

    Article • Seminars in Thrombosis and Hemostasis, June 2012, Thieme Publishing Group

    Dr Emmanuel J Favaloro, Dr Gabriel Lima-Oliveira

  88. Patient Safety and Quality in Laboratory and Hemostasis Testing: A Renewed Loop?

    Article • Seminars in Thrombosis and Hemostasis, June 2012, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  89. Laboratory identification of factor inhibitors: an update

    Article • Pathology, June 2012, Elsevier

    Dr Emmanuel J Favaloro

  90. Paradoxical thrombosis part 1: factor replacement therapy, inherited clotting factor deficiencies and prolonged APTT

    Article • Journal of Thrombosis and Thrombolysis, May 2012, Springer Science + Business Media

    Dr Emmanuel J Favaloro

  91. Paradoxical thrombosis, part 2: anticoagulant and antiplatelet therapy

    Article • Journal of Thrombosis and Thrombolysis, May 2012, Springer Science + Business Media

    Dr Emmanuel J Favaloro

  92. The Antiphospholipid Syndrome: Diagnosis, Pathogenesis, Laboratory Testing, and Management

    Article • Seminars in Thrombosis and Hemostasis, May 2012, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  93. Internal Quality Control and External Quality Assurance in Testing for Antiphospholipid Antibodies: Part I—Anticardiolipin and Anti-β2-Glycoprotein I Antibodies

    Article • Seminars in Thrombosis and Hemostasis, May 2012, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  94. Internal Quality Control and External Quality Assurance in Testing for Antiphospholipid Antibodies: Part II—Lupus Anticoagulant

    Article • Seminars in Thrombosis and Hemostasis, May 2012, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  95. Diagnosis of von Willebrand Disease

    Article • April 2012, Wiley

    Dr Emmanuel J Favaloro

  96. Evaluating laboratory approaches to the identification of lupus anticoagulants: A diagnostic challenge from the RCPA Haematology QAP

    Article • Pathology, April 2012, Elsevier

    Dr Emmanuel J Favaloro

  97. Relationship between short activated partial thromboplastin times, thrombin generation, procoagulant factors and procoagulant phospholipid activity

    Article • Blood Coagulation & Fibrinolysis, April 2012, Wolters Kluwer Health

    Dr Emmanuel J Favaloro

  98. Clinical audit of antiphospholipid antibody testing in tertiary practice: towards improved relevance in thrombophilia investigations

    Article • Internal Medicine Journal, April 2012, Wiley

    Dr Emmanuel J Favaloro

  99. Biological therapies for von Willebrand disease

    Article • Expert Opinion on Biological Therapy, March 2012, Informa Healthcare

    Dr Emmanuel J Favaloro

  100. Coagulopathies and Thrombosis: Usual and Unusual Causes and Associations, Part VI

    Article • Seminars in Thrombosis and Hemostasis, March 2012, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  101. Coffee Intake and Cardiovascular Disease: Virtue Does Not Take Center Stage

    Article • Seminars in Thrombosis and Hemostasis, February 2012, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  102. Hemostatic Properties of the Lymph: Relationships with Occlusion and Thrombosis

    Article • Seminars in Thrombosis and Hemostasis, February 2012, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  103. Hot Topics III

    Article • Seminars in Thrombosis and Hemostasis, February 2012, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  104. Welcome to Seminars in Thrombosis & Hemostasis 2012

    Article • Seminars in Thrombosis and Hemostasis, February 2012, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  105. 2B or not 2B? Masquerading as von Willebrand disease?

    Article • Journal of Thrombosis and Haemostasis, February 2012, Elsevier

    Dr Emmanuel J Favaloro

  106. Pre-analytical Variables in Coagulation Testing Associated With Diagnostic Errors in Hemostasis

    Article • Laboratory Medicine, February 2012, Oxford University Press (OUP)

    Dr Emmanuel J Favaloro

  107. The new oral anticoagulants and the future of haemostasis laboratory testing

    Article • Biochemia Medica, January 2012, Croatian Society for Medical Biochemistry and Laboratory Medicine

    Dr Emmanuel J Favaloro

  108. Proficiency testing/external quality assurance for the PFA-100®

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2012, De Gruyter

    Dr Emmanuel J Favaloro

  109. Influence of mechanical trauma of blood and hemolysis on PFA-100 testing

    Article • Blood Coagulation & Fibrinolysis, January 2012, Wolters Kluwer Health

    Dr Emmanuel J Favaloro

  110. Biomedical research platforms and their influence on article submissions and journal rankings: An update

    Article • Biochemia Medica, January 2012, Croatian Society for Medical Biochemistry and Laboratory Medicine

    Dr Emmanuel J Favaloro

  111. Standards and reference materials for the anticardiolipin and anti-β2glycoprotein I assays: A report of recommendations from the APL Task Force at the 13th International Congress on Antiphospholipid Antibodies

    Article • Clinica Chimica Acta, January 2012, Elsevier

    Dr Emmanuel J Favaloro

  112. International consensus guidelines on anticardiolipin and anti–β2‐glycoprotein I testing: Report from the 13th International Congress on Antiphospholipid Antibodies

    Article • Arthritis & Rheumatism, December 2011, Wiley

    Dr Emmanuel J Favaloro

  113. Antisense therapy in the treatment of hypercholesterolemia

    Article • European Journal of Internal Medicine, December 2011, Elsevier

    Dr Emmanuel J Favaloro

  114. Laboratory testing of anticoagulants: the present and the future

    Article • Pathology, December 2011, Elsevier

    Dr Emmanuel J Favaloro

  115. A robust method for testing urinary iodine using a microtitre robotic system

    Article • Journal of Trace Elements in Medicine and Biology, December 2011, Elsevier

    Dr Emmanuel J Favaloro

  116. Iodine Deficiency: Current Aspects and Future Prospects

    Article • Laboratory Medicine, December 2011, Oxford University Press (OUP)

    Dr Emmanuel J Favaloro

  117. Direct-to-consumer testing: more risks than opportunities

    Article • International Journal of Clinical Practice, November 2011, Hindawi Publishing Corporation

    Dr Emmanuel J Favaloro

  118. Holiday Thrombosis

    Article • Seminars in Thrombosis and Hemostasis, November 2011, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  119. Seminars in Thrombosis & Hemostasis 2010: Impact Factor and Highest-Cited Articles from 2008 to 2009

    Article • Seminars in Thrombosis and Hemostasis, November 2011, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  120. Coagulopathies and Thrombosis: Usual and Unusual Causes and Associations. Part V.

    Article • Seminars in Thrombosis and Hemostasis, November 2011, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  121. Diagnosis and classification of von Willebrand disease

    Article • Blood Coagulation & Fibrinolysis, October 2011, Wolters Kluwer Health

    Dr Emmanuel J Favaloro

  122. von Willebrand Factor Assay Proficiency Testing Continued

    Article • American Journal of Clinical Pathology, September 2011, Oxford University Press (OUP)

    Dr Emmanuel J Favaloro

  123. Thrombocytopenic Platelet Disorders

    Article • Seminars in Thrombosis and Hemostasis, September 2011, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  124. Diagnosis of type 1 vs. 2A and 2M von Willebrand disease

    Article • Haemophilia, August 2011, Wiley

    Dr Emmanuel J Favaloro

  125. Cycling: To Race or to Live – Reflections on Skewed Priorities?

    Article • International Journal of Sports Medicine, August 2011, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  126. Distinguishing types 1 and 2M von Willebrand disease

    Article • International Journal of Laboratory Hematology, July 2011, Wiley

    Dr Emmanuel J Favaloro

  127. Diagnosis and Management of v on Willebrand Disease in Australia

    Article • Seminars in Thrombosis and Hemostasis, July 2011, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  128. von Willebrand Disease: Local Diagnosis and Management of a Globally Distributed Bleeding Disorder

    Article • Seminars in Thrombosis and Hemostasis, July 2011, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  129. 2011 Eberhard F. Mammen Award Announcements

    Article • Seminars in Thrombosis and Hemostasis, July 2011, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  130. Michael Dawson, B. Pharm. (Hon), Ph.D. (1954–2010)

    Article • Seminars in Thrombosis and Hemostasis, July 2011, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  131. v on Willebrand Disease: Local Diagnosis and Management of a Globally Distributed Bleeding Disorder

    Article • Seminars in Thrombosis and Hemostasis, July 2011, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  132. Assessment for antithrombin deficiency in the real world

    Article • International Journal of Laboratory Hematology, June 2011, Wiley

    Dr Emmanuel J Favaloro

  133. Regulation of in vitro diagnostics (IVDs) for use in Australian pathology laboratories: a gloomy outlook for future pathology testing in this country?

    Article • Pathology, June 2011, Elsevier

    Dr Emmanuel J Favaloro

  134. Inherited disorders of blood coagulation

    Article • Annals of Medicine, May 2011, Taylor & Francis

    Dr Emmanuel J Favaloro

  135. Laboratory testing and/or monitoring of the new oral anticoagulants/antithrombotics: for and against?

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), May 2011, De Gruyter

    Dr Emmanuel J Favaloro

  136. Laboratory diagnostics and appropriate care of people with haemophilia

    Article • Haemophilia, April 2011, Wiley

    Dr Emmanuel J Favaloro

  137. Inherited and acquired factor V deficiency

    Article • Blood Coagulation & Fibrinolysis, April 2011, Wolters Kluwer Health

    Dr Emmanuel J Favaloro

  138. A clinical audit of congenital thrombophilia investigation in tertiary practice

    Article • Pathology, April 2011, Elsevier

    Dr Emmanuel J Favaloro

  139. External quality assurance for the PFA‐100®

    Article • Journal of Thrombosis and Haemostasis, April 2011, Elsevier

    Dr Emmanuel J Favaloro

  140. Prevention of Venous Thromboembolism: Focus on Mechanical Prophylaxis

    Article • Seminars in Thrombosis and Hemostasis, March 2011, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  141. Coagulopathies and Thrombosis: Usual and Unusual Causes and Associations, Part IV

    Article • Seminars in Thrombosis and Hemostasis, March 2011, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  142. Obstructive Sleep Apnea Syndrome and Cardiovascular Diseases

    Article • Seminars in Thrombosis and Hemostasis, March 2011, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  143. Laboratory Diagnosis of von Willebrand Disease: The Phenotype

    Article • March 2011, Wiley

    Dr Emmanuel J Favaloro

  144. Venous Thromboembolism in Chronic Liver Disease

    Article • Seminars in Thrombosis and Hemostasis, February 2011, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  145. Glycoprotein IIb/IIIa inhibitors: an update on the mechanism of action and use of functional testing methods to assess antiplatelet efficacy

    Article • Biomarkers in Medicine, February 2011, Future Medicine

    Dr Emmanuel J Favaloro

  146. Functional analysis of three recombinant A1-VWF domain mutants in comparison to wild type and plasma-derived VWF facilitates subtyping in type 2 von Willebrand disease

    Article • Thrombosis Research, February 2011, Elsevier

    Dr Emmanuel J Favaloro

  147. More on preanalytical variables affecting platelet function testing using light transmittance aggregometry

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2011, De Gruyter

    Dr Emmanuel J Favaloro

  148. Laboratory testing for the antiphospholipid syndrome: making sense of antiphospholipid antibody assays

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2011, De Gruyter

    Dr Emmanuel J Favaloro

  149. Hormones, Endocrine Disorders, and Hemostasis

    Article • Seminars in Thrombosis and Hemostasis, January 2011, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  150. The Spectrum of Coagulation Abnormalities in Thyroid Disorders

    Article • Seminars in Thrombosis and Hemostasis, January 2011, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  151. Rethinking the diagnosis of von Willebrand disease

    Article • Thrombosis Research, January 2011, Elsevier

    Dr Emmanuel J Favaloro

  152. Coagulation update: What's new in hemostasis testing?

    Article • Thrombosis Research, January 2011, Elsevier

    Dr Emmanuel J Favaloro

  153. Regulation of in vitro diagnostics (IVDs) for use in clinical diagnostic laboratories: towards the light or dark in clinical laboratory testing?

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2011, De Gruyter

    Dr Emmanuel J Favaloro

  154. Interaction of factor VIII and von Willebrand factor and the identification of type 2N von Willebrand disease

    Article • Thrombosis Research, January 2011, Elsevier

    Dr Emmanuel J Favaloro

  155. Studies on in vitro hemolysis and utility of corrective formulas for reporting results on hemolyzed specimens

    Article • Biochemia Medica, January 2011, Croatian Society for Medical Biochemistry and Laboratory Medicine

    Dr Emmanuel J Favaloro

  156. Laboratory investigation of lupus anticoagulants: mixing studies are sometimes required

    Article • Journal of Thrombosis and Haemostasis, December 2010, Elsevier

    Dr Emmanuel J Favaloro

  157. Validation of improved performance characteristics for the automated von Willebrand factor ristocetin cofactor activity assay

    Article • Journal of Thrombosis and Haemostasis, December 2010, Elsevier

    Dr Emmanuel J Favaloro

  158. Farewell to 2010!

    Article • Seminars in Thrombosis and Hemostasis, November 2010, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  159. Global Hemostasis: New Approaches to Patient Diagnosis and Treatment Monitoring

    Article • Seminars in Thrombosis and Hemostasis, October 2010, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  160. Winners of the 2010 Eberhard F. Mammen Award for Most Popular Article during 2008–2009

    Article • Seminars in Thrombosis and Hemostasis, October 2010, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  161. Hemolytic Uremic Syndrome

    Article • Seminars in Thrombosis and Hemostasis, September 2010, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  162. C-reactive protein and venous thromboembolism: causal or casual association?

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), August 2010, De Gruyter

    Dr Emmanuel J Favaloro

  163. Recombinants in Thrombosis and Hemostasis: From Basic Research to Clinical Therapy

    Article • Seminars in Thrombosis and Hemostasis, July 2010, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  164. Recombinant Platelet Factor 4: A Therapeutic, Anti-Neoplastic Chimera?

    Article • Seminars in Thrombosis and Hemostasis, July 2010, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  165. 2009 Eberhard F. Mammen Young Investigator Award Winners

    Article • Seminars in Thrombosis and Hemostasis, July 2010, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  166. Thrombotic Complications of Erythropoiesis-Stimulating Agents

    Article • Seminars in Thrombosis and Hemostasis, July 2010, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  167. Shortened activated partial thromboplastin time: causes and management

    Article • Blood Coagulation & Fibrinolysis, July 2010, Wolters Kluwer Health

    Dr Emmanuel J Favaloro

  168. Quality issues in laboratory haemostasis

    Article • Haemophilia, June 2010, Wiley

    Dr Emmanuel J Favaloro

  169. Laboratory identification of factor VIII inhibitors in the real world: the experience from Australasia

    Article • Haemophilia, June 2010, Wiley

    Dr Emmanuel J Favaloro

  170. Laboratory Testing in Disseminated Intravascular Coagulation

    Article • Seminars in Thrombosis and Hemostasis, June 2010, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  171. Laboratory testing in pharmacies

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), May 2010, De Gruyter

    Dr Emmanuel J Favaloro

  172. Improving the harmonisation of the International Normalized Ratio (INR): time to think outside the box?

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), May 2010, De Gruyter

    Dr Emmanuel J Favaloro

  173. UNSUSPECTED COAGULOPATHY RARELY PREVENTS IV THROMBOLYSIS IN ACUTE ISCHEMIC STROKE

    Article • Neurology, May 2010, Wolters Kluwer Health

    Dr Emmanuel J Favaloro

  174. Laboratory medicine and natural disasters: are we ready for the challenge?

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), May 2010, De Gruyter

    Dr Emmanuel J Favaloro

  175. The antiphospholipid syndrome: a large elephant with many parts or an elusive chameleon disguised by many colours?

    Article • Autoimmunity Highlights, May 2010, Springer Science + Business Media

    Dr Emmanuel J Favaloro

  176. Problems in laboratory testing: hemophilia and beyond

    Article • Journal of Thrombosis and Haemostasis, May 2010, Elsevier

    Dr Emmanuel J Favaloro

  177. Under-Recognized Significance of Endothelial Heterogeneity: Hemostasis, Thrombosis, and Beyond

    Article • Seminars in Thrombosis and Hemostasis, April 2010, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  178. Proteomic analysis of venous thromboembolism

    Article • Expert Review of Proteomics, April 2010, Taylor & Francis

    Dr Emmanuel J Favaloro

  179. Genetic testing in von Willebrand disease: reply to rebuttal

    Article • Journal of Thrombosis and Haemostasis, April 2010, Elsevier

    Dr Emmanuel J Favaloro

  180. Biochemical markers for the diagnosis of venous thromboembolism: the past, present and future

    Article • Journal of Thrombosis and Thrombolysis, March 2010, Springer Science + Business Media

    Dr Emmanuel J Favaloro

  181. Platelets, Inflammation and Cardiovascular Diseases. New Concepts and Therapeutic Implications

    Article • Seminars in Thrombosis and Hemostasis, March 2010, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  182. A laboratory evaluation into the short activated partial thromboplastin time

    Article • Blood Coagulation & Fibrinolysis, March 2010, Wolters Kluwer Health

    Dr Emmanuel J Favaloro

  183. Mild hemophilia A

    Article • Journal of Thrombosis and Haemostasis, March 2010, Elsevier

    Dr Emmanuel J Favaloro

  184. Contemporary platelet function testing

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), February 2010, De Gruyter

    Dr Emmanuel J Favaloro

  185. Coagulopathies and Thrombosis: Usual and Unusual Causes and Associations, Part III

    Article • Seminars in Thrombosis and Hemostasis, February 2010, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  186. Influenza and Cardiovascular Disease: Does Swine-Origin, 2009 H1N1 Flu Virus Represent a Risk Factor, an Acute Trigger, or Both?

    Article • Seminars in Thrombosis and Hemostasis, February 2010, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  187. Moderate Red Wine Consumption and Cardiovascular Disease Risk: Beyond the “French Paradox”

    Article • Seminars in Thrombosis and Hemostasis, February 2010, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  188. Quality in coagulation and haemostasis testing

    Article • Biochemia Medica, January 2010, Croatian Society for Medical Biochemistry and Laboratory Medicine

    Dr Emmanuel J Favaloro

  189. Hemophilia, cancer and cardiovascular disease

    Article • Blood Coagulation & Fibrinolysis, January 2010, Wolters Kluwer Health

    Dr Emmanuel J Favaloro

  190. Glanzmann thrombasthenia: An update

    Article • Clinica Chimica Acta, January 2010, Elsevier

    Dr Emmanuel J Favaloro

  191. Genetic testing for von Willebrand disease: the case against

    Article • Journal of Thrombosis and Haemostasis, January 2010, Elsevier

    Dr Emmanuel J Favaloro

  192. Laboratory reporting of hemostasis assays: the final post-analytical opportunity to reduce errors of clinical diagnosis in hemostasis?

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), December 2009, De Gruyter

    Dr Emmanuel J Favaloro

  193. Identification and prevalence of von Willebrand disease type 2N (Normandy) in Australia

    Article • Blood Coagulation & Fibrinolysis, December 2009, Wolters Kluwer Health

    Dr Emmanuel J Favaloro

  194. Current clinical and laboratory practice for the investigation of the antiphospholipid syndrome: findings from the 2008 Australasian antiphospholipid antibody survey

    Article • Pathology, December 2009, Elsevier

    Dr Emmanuel J Favaloro

  195. Emanuele Favaloro (1920–2009) and Francesca Favaloro (1922–2009)

    Article • Seminars in Thrombosis and Hemostasis, November 2009, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  196. Farewell to 2009!

    Article • Seminars in Thrombosis and Hemostasis, November 2009, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  197. Identification, Pathogenesis, and Treatment of Factor Inhibitors

    Article • Seminars in Thrombosis and Hemostasis, November 2009, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  198. Investigations from External Quality Assurance Programs Reveal a High Degree of Variation in the Laboratory Identification of Coagulation Factor Inhibitors

    Article • Seminars in Thrombosis and Hemostasis, November 2009, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  199. Winners of the Inaugural Eberhard F. Mammen Award for Most Popular Article

    Article • Seminars in Thrombosis and Hemostasis, October 2009, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  200. Coagulopathies and Thrombosis: Usual and Unusual Causes and Associations, Part II

    Article • Seminars in Thrombosis and Hemostasis, October 2009, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  201. Laboratory Investigation of Thrombophilia: The Good, the Bad, and the Ugly

    Article • Seminars in Thrombosis and Hemostasis, October 2009, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  202. Unsuspected Triggers of Venous Thromboembolism—Trivial or Not So Trivial?

    Article • Seminars in Thrombosis and Hemostasis, October 2009, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  203. Prostate-Specific Antigen, Prostate Cancer, and Disorders of Hemostasis

    Article • Seminars in Thrombosis and Hemostasis, October 2009, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  204. The Bidirectional Relationship of Cancer and Hemostasis and the Potential Role of Anticoagulant Therapy in Moderating Thrombosis and Cancer Spread

    Article • Seminars in Thrombosis and Hemostasis, October 2009, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  205. Potential supplementary utility of combined PFA-100 and functional von Willebrand factor testing for the laboratory assessment of desmopressin and factor concentrate therapy in von Willebrand disease

    Article • Blood Coagulation & Fibrinolysis, September 2009, Wolters Kluwer Health

    Dr Emmanuel J Favaloro

  206. D-Dimer Measurement and Laboratory Feedback

    Article • Journal of Emergency Medicine, July 2009, Elsevier

    Dr Emmanuel J Favaloro

  207. Laboratory assessment and perioperative management of patients on antiplatelet therapy: From the bench to the bedside

    Article • Clinica Chimica Acta, July 2009, Elsevier

    Dr Emmanuel J Favaloro

  208. Relationship between 24-h air pollution, emergency department admission and diagnosis of acute coronary syndrome

    Article • Journal of Thrombosis and Thrombolysis, June 2009, Springer Science + Business Media

    Dr Emmanuel J Favaloro

  209. The role of ethnicity, age and gender in venous thromboembolism

    Article • Journal of Thrombosis and Thrombolysis, June 2009, Springer Science + Business Media

    Dr Emmanuel J Favaloro

  210. Time to seek further clarity in the molecular analysis of von Willebrand disease?

    Article • Thrombosis and Haemostasis, June 2009, Schattauer GmbH

    Dr Emmanuel J Favaloro

  211. Rare Bleeding Disorders

    Article • Seminars in Thrombosis and Hemostasis, June 2009, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  212. Rodger L. Bick, M.D., Ph.D., FACP (1943–2008)

    Article • Seminars in Thrombosis and Hemostasis, April 2009, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  213. Coagulopathies and Thrombosis: Usual and Unusual Causes and Associations, Part I

    Article • Seminars in Thrombosis and Hemostasis, April 2009, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  214. Mental Depression and Cardiovascular Disease: A Multifaceted, Bidirectional Association

    Article • Seminars in Thrombosis and Hemostasis, April 2009, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  215. Desmopressin therapy to assist the functional identification and characterisation of von Willebrand disease: Differential utility from combining two (VWF:CB and VWF:RCo) von Willebrand factor activity assays?

    Article • Thrombosis Research, April 2009, Elsevier

    Dr Emmanuel J Favaloro

  216. Internal Quality Control and External Quality Assurance of Platelet Function Tests

    Article • Seminars in Thrombosis and Hemostasis, March 2009, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  217. Diagnostic Evaluation of Platelet Disorders: The Past, the Present, and the Future

    Article • Seminars in Thrombosis and Hemostasis, March 2009, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  218. Welcome to the First Issue of Seminars in Thrombosis and Hemostasis for 2009

    Article • Seminars in Thrombosis and Hemostasis, February 2009, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  219. Milestones and Perspectives in Coagulation and Hemostasis

    Article • Seminars in Thrombosis and Hemostasis, February 2009, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  220. Relationship between activated partial thromboplastin time, heparin and potassium levels

    Article • Diabetes Research and Clinical Practice, February 2009, Elsevier

    Dr Emmanuel J Favaloro

  221. Laboratory Diagnostics and Therapy in Thrombosis and Hemostasis: From Bedside to Bench to Bedside

    Article • Seminars in Thrombosis and Hemostasis, February 2009, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  222. Toward a New Paradigm for the Identification and Functional Characterization of von Willebrand Disease

    Article • Seminars in Thrombosis and Hemostasis, February 2009, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  223. High Rate of Deficiency in the Amino Acids Tryptophan and Histidine in People with Wounds

    Article • Advances in Skin & Wound Care, February 2009, Wolters Kluwer Health

    Dr Emmanuel J Favaloro

  224. The missing link between genotype, phenotype and clinics

    Article • Biochemia Medica, January 2009, Croatian Society for Medical Biochemistry and Laboratory Medicine

    Dr Emmanuel J Favaloro

  225. Pharmacogenetics of vitamin K antagonists: useful or hype?

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2009, De Gruyter

    Dr Emmanuel J Favaloro

  226. The Journal Impact Factor: don't expect its demise any time soon

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2009, De Gruyter

    Dr Emmanuel J Favaloro

  227. Diagnosis of von willebrand disease (VWD): towards a new paradigm for the identification and functional characterisation of VWD

    Article • Pathology, January 2009, Elsevier

    Dr Emmanuel J Favaloro

  228. One-stage clotting versus chromogenic assays for assessing recombinant factor VIII: two faces of a haemostasis coin

    Article • Blood Coagulation & Fibrinolysis, January 2009, Wolters Kluwer Health

    Dr Emmanuel J Favaloro

  229. Survey on the prevalence of hemolytic specimens in an academic hospital according to collection facility: opportunities for quality improvement

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2009, De Gruyter

    Dr Emmanuel J Favaloro

  230. Epidemiological association between fasting plasma glucose and shortened APTT

    Article • Clinical Biochemistry, January 2009, Elsevier

    Dr Emmanuel J Favaloro

  231. Laboratory Evaluation of von Willebrand Disease: Phenotypic Analysis

    Article • December 2008, Wiley

    Dr Emmanuel J Favaloro

  232. Aspirin ‘responsiveness’, ‘nonresponsiveness’ or ‘resistance’: a putative role for von Willebrand factor?

    Article • Blood Coagulation & Fibrinolysis, December 2008, Wolters Kluwer Health

    Dr Emmanuel J Favaloro

  233. Welcome to a Special Issue of Seminars in Thrombosis and Hemostasis —The Closing Issue for 2008

    Article • Seminars in Thrombosis and Hemostasis, November 2008, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  234. A Tribute to Eberhard F. Mammen, M.D. (1930–2008)

    Article • Seminars in Thrombosis and Hemostasis, November 2008, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  235. Clinical Utility of the PFA-100

    Article • Seminars in Thrombosis and Hemostasis, November 2008, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  236. Activated Partial Thromboplastin Time: New Tricks for an Old Dogma

    Article • Seminars in Thrombosis and Hemostasis, October 2008, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  237. Laboratory Diagnostics in Thrombosis and Hemostasis: The Past, the Present, and the Future

    Article • Seminars in Thrombosis and Hemostasis, October 2008, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  238. Standardization of the INR: How Good Is Your Laboratory's INR and Can It Be Improved?

    Article • Seminars in Thrombosis and Hemostasis, October 2008, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  239. Preanalytical and Postanalytical Variables: The Leading Causes of Diagnostic Error in Hemostasis?

    Article • Seminars in Thrombosis and Hemostasis, October 2008, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  240. Dark chocolate: consumption for pleasure or therapy?

    Article • Journal of Thrombosis and Thrombolysis, September 2008, Springer Science + Business Media

    Dr Emmanuel J Favaloro

  241. Hyperthyroidism is associated with shortened APTT and increased fibrinogen values in a general population of unselected outpatients

    Article • Journal of Thrombosis and Thrombolysis, September 2008, Springer Science + Business Media

    Dr Emmanuel J Favaloro

  242. Salbutamol in Athletes

    Article • Clinical Journal of Sport Medicine, September 2008, Wolters Kluwer Health

    Dr Emmanuel J Favaloro

  243. Genetics of type 2B von Willebrand Disease: “True 2B,” “tricky 2B,” or “Not 2B.” What Are the Modifiers of the Phenotype?

    Article • Seminars in Thrombosis and Hemostasis, September 2008, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  244. A better approach to monitoring of therapy in von Willebrand disease?

    Article • Thrombosis and Haemostasis, August 2008, Schattauer GmbH

    Dr Emmanuel J Favaloro

  245. Differential identification of PT‐VWD from type 2B VWD and GP1BA nomenclature issues response to Othman

    Article • British Journal of Haematology, June 2008, Wiley

    Dr Emmanuel J Favaloro

  246. The genetic basis of human athletic performance. Why are psychological components so often overlooked?

    Article • The Journal of Physiology, June 2008, Wiley

    Dr Emmanuel J Favaloro

  247. Antiphospholipid Antibodies and the Antiphospholipid Syndrome II: Limitations, Standardization, and Clinical Utility of Laboratory Testing

    Article • Seminars in Thrombosis and Hemostasis, June 2008, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  248. Laboratory Testing and Identification of Antiphospholipid Antibodies and the Antiphospholipid Syndrome: A Potpourri of Problems, a Compilation of Possible Solutions

    Article • Seminars in Thrombosis and Hemostasis, June 2008, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  249. A Consensus Approach to the Formulation of Guidelines for Laboratory Testing and Reporting of Antiphospholipid Antibody Assays

    Article • Seminars in Thrombosis and Hemostasis, June 2008, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  250. The paradoxical relationship between serum uric acid and cardiovascular disease

    Article • Clinica Chimica Acta, June 2008, Elsevier

    Dr Emmanuel J Favaloro

  251. Cardiac biomarkers in pulmonary embolism

    Article • Thrombosis and Haemostasis, May 2008, Schattauer GmbH

    Dr Emmanuel J Favaloro

  252. Stability of coagulation assays performed in plasma from citrated whole blood transported at ambient temperature: Only a part of the story

    Article • Thrombosis and Haemostasis, May 2008, Schattauer GmbH

    Dr Emmanuel J Favaloro

  253. Potential benefits of improved protein intake in older people

    Article • Nutrition & Dietetics, May 2008, Wiley

    Dr Emmanuel J Favaloro

  254. Clinical Features, Diagnosis, and Management of the Antiphospholipid Syndrome

    Article • Seminars in Thrombosis and Hemostasis, April 2008, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  255. Professor Ronald A. Asherson, M.D. (Hon), F.R.C.P., M.D., F.A.C.P., F.C.P., F.A.C.R., Dip. O&G (Hon) [1934–2008]

    Article • Seminars in Thrombosis and Hemostasis, April 2008, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  256. Antiphospholipid Antibodies and the Antiphospholipid Syndrome I: Pathogenesis, Clinical Features, Diagnosis, and Management

    Article • Seminars in Thrombosis and Hemostasis, April 2008, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  257. The LOC387715 Polymorphism, Inflammatory Markers, Smoking, and Age-Related Macular Degeneration

    Article • Ophthalmology, April 2008, Elsevier

    Dr Emmanuel J Favaloro

  258. von Willebrand disease, type 2B: A diagnosis more elusive than previously thought

    Article • Thrombosis and Haemostasis, February 2008, Schattauer GmbH

    Dr Emmanuel J Favaloro

  259. Welcome to Seminars in Thrombosis and Hemostasis -2008!

    Article • Seminars in Thrombosis and Hemostasis, February 2008, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  260. Measuring the Quality of Journals and Journal Articles: The Impact Factor Tells but a Portion of the Story

    Article • Seminars in Thrombosis and Hemostasis, February 2008, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  261. Hot Topics II: An Editorial Collection of Current Issues and Controversies in Thrombosis and Hemostasis

    Article • Seminars in Thrombosis and Hemostasis, February 2008, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  262. Phenotypic Identification of Platelet-Type von Willebrand Disease and Its Discrimination from Type 2B von Willebrand Disease: A Question of 2B or Not 2B? A Story of Nonidentical Twins? Or Two Sides of a Multidenominational or Multifaceted Primary-Hemos...

    Article • Seminars in Thrombosis and Hemostasis, February 2008, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  263. Detection of duplicates and redundancies. A major responsibility of peer-reviewers?

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2008, De Gruyter

    Dr Emmanuel J Favaloro

  264. Help me, Doctor! My D-dimer is raised

    Article • Annals of Medicine, January 2008, Taylor & Francis

    Dr Emmanuel J Favaloro

  265. Protein Z is reduced in chronic kidney disease and not elevated in patients on haemodialysis

    Article • Blood Coagulation & Fibrinolysis, January 2008, Wolters Kluwer Health

    Dr Emmanuel J Favaloro

  266. Air pollution and coagulation testing: A new source of biological variability?

    Article • Thrombosis Research, January 2008, Elsevier

    Dr Emmanuel J Favaloro

  267. A practical approach to instrument selection, evaluation, basic financial management and implementation in pathology and research

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2008, De Gruyter

    Dr Emmanuel J Favaloro

  268. The Diagnostic Dilemma: Dual Presentations of Clinical Mucosal Bleeding and Venous Thrombosis Associated with the Presence of Thrombophilia Markers and Mild Reduction in von Willebrand Factor

    Article • Laboratory Hematology, December 2007, Carden Jennings Publishing Co.

    Dr Emmanuel J Favaloro

  269. Hot Topics I: A Potpourri of Current Issues and Controversies in Thrombosis and Hemostasis

    Article • Seminars in Thrombosis and Hemostasis, November 2007, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  270. An Update on the von Willebrand Factor Collagen Binding Assay: 21 Years of Age and Beyond Adolescence but Not Yet a Mature Adult

    Article • Seminars in Thrombosis and Hemostasis, November 2007, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  271. Hemostatic Dysfunction Associated with Endocrine Disorders as a Major Risk Factor and Cause of Human Morbidity and Mortality: A Comprehensive Meta-review

    Article • Seminars in Thrombosis and Hemostasis, November 2007, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  272. Time to Think Outside the Box? Proposals for a New Approach to Future Pharmacokinetic Studies of von Willebrand Factor Concentrates in People with von Willebrand Disease

    Article • Seminars in Thrombosis and Hemostasis, November 2007, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  273. Differential identification of a rare form of platelet‐type (pseudo‐) von Willebrand disease (VWD) from Type 2B VWD using a simplified ristocetin‐induced‐platelet‐agglutination mixing assay and confirmed by genetic analysis

    Article • British Journal of Haematology, October 2007, Wiley

    Dr Emmanuel J Favaloro

  274. Mis-identification of factor inhibitors by diagnostic haemostasis laboratories: recognition of pitfalls and elucidation of strategies. A follow up to a large multicentre evaluation

    Article • Pathology, October 2007, Elsevier

    Dr Emmanuel J Favaloro

  275. More on the impact factor and thrombosis and haemostasis journals: Benefits and limitations

    Article • Thrombosis and Haemostasis, July 2007, Schattauer GmbH

    Dr Emmanuel J Favaloro

  276. 2B or not 2B? Disparate discrimination of functional VWF discordance using different assay panels or methodologies may lead to success or failure in the early identification of type 2B VWD

    Article • Thrombosis and Haemostasis, July 2007, Schattauer GmbH

    Dr Emmanuel J Favaloro

  277. Utility of the PFA-100 as a screening test of platelet function: an audit of haemostasis laboratories in Australia and New Zealand

    Article • Blood Coagulation & Fibrinolysis, July 2007, Wolters Kluwer Health

    Dr Emmanuel J Favaloro

  278. Comparison of the pharmacokinetics of two von Willebrand factor concentrates [Biostate and AHF (High Purity)] in people with von Willebrand disorder. A randomised cross-over, multi-centre study

    Article • Thrombosis and Haemostasis, April 2007, Schattauer GmbH

    Dr Emmanuel J Favaloro

  279. Standardization, Quality Assurance, and Emerging Diagnostic Technologies in Hemostasis

    Article • Seminars in Thrombosis and Hemostasis, April 2007, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  280. Emerging Technologies and Quality Assurance in Hemostasis: A Review of Findings from the Royal College of Pathologists of Australasia Quality Assurance Program

    Article • Seminars in Thrombosis and Hemostasis, April 2007, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  281. Standardization, Regulation, Quality Assurance and Emerging Technologies in Hemostasis: Issues, Controversies, Benefits, and Limitations

    Article • Seminars in Thrombosis and Hemostasis, April 2007, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  282. A Review of β 2 -Glycoprotein-I Antibody Testing Results From a Peer-Driven Multilaboratory Quality Assurance Program

    Article • American Journal of Clinical Pathology, March 2007, Oxford University Press (OUP)

    Dr Emmanuel J Favaloro

  283. Investigating people with mucocutaneous bleeding suggestive of primary hemostatic defects: a low likelihood of a definitive diagnosis?

    Article • Haematologica, March 2007, Ferrata Storti Foundation (Haematologica)

    Dr Emmanuel J Favaloro

  284. Preanalytical variables in coagulation testing

    Article • Blood Coagulation & Fibrinolysis, January 2007, Wolters Kluwer Health

    Dr Emmanuel J Favaloro

  285. Thrombophilia and Cerebral Vein Thrombosis

    Article • January 2007, Karger Publishers

    Dr Emmanuel J Favaloro

  286. Increased Propensity to Bruising in Red-Haired Females: A Possible Role for von Willebrand Factor?

    Article • Anesthesia & Analgesia, December 2006, Wolters Kluwer Health

    Dr Emmanuel J Favaloro

  287. 2B or not 2B? Differential identification of type 2B, versus pseudo‐, von Willebrand disease – response to Whalley and Perry

    Article • British Journal of Haematology, November 2006, Wiley

    Dr Emmanuel J Favaloro

  288. Laboratory Monitoring of Therapy in von Willebrand Disease: Efficacy of the PFA-100 and von Willebrand Factor:Collagen-Binding Activity as Coupled Strategies

    Article • Seminars in Thrombosis and Hemostasis, September 2006, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  289. More on: platelet function analyser (PFA)‐100® closure time in the evaluation of platelet disorders and platelet function

    Article • Journal of Thrombosis and Haemostasis, September 2006, Elsevier

    Dr Emmanuel J Favaloro

  290. 2B or not 2B? Differential identification of type 2B, versus pseudo‐von Willebrand disease

    Article • British Journal of Haematology, August 2006, Wiley

    Dr Emmanuel J Favaloro

  291. Laboratory Identification of von Willebrand Disease: Technical and Scientific Perspectives

    Article • Seminars in Thrombosis and Hemostasis, July 2006, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  292. The Utility of the PFA-100 in the Identification of von Willebrand Disease: A Concise Review

    Article • Seminars in Thrombosis and Hemostasis, July 2006, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  293. Reducing Errors in Identification of von Willebrand Disease: The Experience of the Royal College of Pathologists of Australasia Quality Assurance Program

    Article • Seminars in Thrombosis and Hemostasis, July 2006, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  294. More on ‘universal’versus‘selected’ screening for thrombophilia: the hidden costs of false‐positive diagnosis

    Article • British Journal of Haematology, June 2006, Wiley

    Dr Emmanuel J Favaloro

  295. Identification of factor inhibitors by diagnostic haemostasis laboratories. A large multi-centre evaluation

    Article • Thrombosis and Haemostasis, June 2006, Schattauer GmbH

    Dr Emmanuel J Favaloro

  296. Unrecognized pellagra masquerading as odynophagia

    Article • Internal Medicine Journal, June 2006, Wiley

    Dr Emmanuel J Favaloro

  297. Effect of overnight 4°C storage of whole blood on von Willebrand factor

    Article • Transfusion, May 2006, Wiley

    Dr Emmanuel J Favaloro

  298. Activated protein C resistance: The influence of ABO-blood group, gender and age

    Article • Thrombosis Research, January 2006, Elsevier

    Dr Emmanuel J Favaloro

  299. Cold storage of citrated whole blood induces drastic time-dependent losses in factor VIII and von Willebrand factor: potential for misdiagnosis of haemophilia and von Willebrand disease

    Article • Blood Coagulation & Fibrinolysis, January 2006, Wolters Kluwer Health

    Dr Emmanuel J Favaloro

  300. Reassessment of ABO Blood Group, Sex, and Age on Laboratory Parameters Used to Diagnose von Willebrand Disorder

    Article • American Journal of Clinical Pathology, December 2005, Oxford University Press (OUP)

    Dr Emmanuel J Favaloro

  301. Cross-laboratory audit of normal reference ranges and assessment of ABO blood group, gender and age on detected levels of plasma coagulation factors

    Article • Blood Coagulation & Fibrinolysis, November 2005, Wolters Kluwer Health

    Dr Emmanuel J Favaloro

  302. How Useful is the Monitoring of (Low Molecular Weight) Heparin Therapy by Anti-Xa Assay? A Laboratory Perspective

    Article • Laboratory Hematology, September 2005, Carden Jennings Publishing Co.

    Dr Emmanuel J Favaloro

  303. Laboratory Identification of Familial Thrombophilia: Do the Pitfalls Exceed the Benefits? A Reassessment of ABO-Blood Group, Gender,Age, and other Laboratory Parameters on the Potential Influence on a Diagnosis of Protein C, Protein S, and Antithromb

    Article • Laboratory Hematology, September 2005, Carden Jennings Publishing Co.

    Dr Emmanuel J Favaloro

  304. A Diet Rich in High-Oleic-Acid Sunflower Oil Favorably Alters Low-Density Lipoprotein Cholesterol, Triglycerides, and Factor VII Coagulant Activity

    Article • Journal of the American Dietetic Association, July 2005, Elsevier

    Dr Emmanuel J Favaloro

  305. An international survey of current practice in the laboratory assessment of anticoagulant therapy with heparin

    Article • Pathology, June 2005, Elsevier

    Dr Emmanuel J Favaloro

  306. Laboratory Diagnosis of von Willebrand Disorder: Use of Multiple Functional Assays Reduces Diagnostic Error Rates

    Article • Laboratory Hematology, June 2005, Carden Jennings Publishing Co.

    Dr Emmanuel J Favaloro

  307. Diagnostic Issues in Thrombophilia: A Laboratory Scientist's View

    Article • Seminars in Thrombosis and Hemostasis, February 2005, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  308. External Quality Assurance of DNA Testing for Thrombophilia Mutations

    Article • American Journal of Clinical Pathology, February 2005, Oxford University Press (OUP)

    Dr Emmanuel J Favaloro

  309. Development of Consensus Guidelines for Anticardiolipin and Lupus Anticoagulant Testing

    Article • Seminars in Thrombosis and Hemostasis, February 2005, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  310. Learning from Peer Assessment: The Role of the External Quality Assurance Multilaboratory Thrombophilia Test Process

    Article • Seminars in Thrombosis and Hemostasis, February 2005, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  311. Multilaboratory Testing of Thrombophilia: Current and Past Practice in Australasia as Assessed through the Royal College of Pathologists of Australasia Quality Assurance Program for Hematology

    Article • Seminars in Thrombosis and Hemostasis, February 2005, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  312. A Multilaboratory Peer Assessment Quality Assurance Program-Based Evaluation of Anticardiolipin Antibody, and beta 2 -Glycoprotein I Antibody Testing

    Article • Seminars in Thrombosis and Hemostasis, February 2005, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  313. Factor V inhibitors

    Article • Blood Coagulation & Fibrinolysis, December 2004, Wolters Kluwer Health

    Dr Emmanuel J Favaloro

  314. Potential Laboratory Misdiagnosis of Hemophilia and von Willebrand Disorder Owing to Cold Activation of Blood Samples for Testing

    Article • American Journal of Clinical Pathology, November 2004, Oxford University Press (OUP)

    Dr Emmanuel J Favaloro

  315. Evaluation of primary haemostasis in people with neurofibromatosis type 1

    Article • International Journal of Laboratory Hematology, October 2004, Wiley

    Dr Emmanuel J Favaloro

  316. A multi-centre evaluation of the intra-assay and inter-assay variation of commercial and in-house anti-cardiolipin antibody assays

    Article • Pathology, April 2004, Elsevier

    Dr Emmanuel J Favaloro

  317. Consensus guidelines on anti-cardiolipin antibody testing and reporting

    Article • Pathology, February 2004, Elsevier

    Dr Emmanuel J Favaloro

  318. Laboratory Diagnosis of von Willebrand Disorder

    Article • American Journal of Clinical Pathology, June 2003, Oxford University Press (OUP)

    Dr Emmanuel J Favaloro

  319. Assessing the Usefulness of Anticardiolipin Antibody Assays

    Article • American Journal of Clinical Pathology, October 2002, Oxford University Press (OUP)

    Dr Emmanuel J Favaloro

  320. Clinical application of the PFA-100®

    Article • Current Opinion in Hematology, September 2002, Wolters Kluwer Health

    Dr Emmanuel J Favaloro

  321. Identification of von Willebrand Disease Type 2N (Normandy) in Australia

    Article • American Journal of Clinical Pathology, August 2002, Oxford University Press (OUP)

    Dr Emmanuel J Favaloro

  322. Treatment of two patients with acquired factor VIII inhibitors using cyclophosphamide and prednisone

    Article • American Journal of Hematology, July 2002, Wiley

    Dr Emmanuel J Favaloro

  323. von Willebrand Factor Collagen-Binding (Activity) Assay in the Diagnosis of von Willebrand Disease: A 15-Year Journey

    Article • Seminars in Thrombosis and Hemostasis, January 2002, Thieme Publishing Group

    Dr Emmanuel J Favaloro

  324. A 9-year retrospective assessment of laboratory testing for activated protein C resistance: evolution of a novel approach to thrombophilia investigations

    Article • Pathology, January 2002, Elsevier

    Dr Emmanuel J Favaloro

  325. Appropriate laboratory assessment as a critical facet in the proper diagnosis and classification of von Willebrand disorder

    Article • Best Practice & Research Clinical Haematology, June 2001, Elsevier

    Dr Emmanuel J Favaloro

  326. Utility of the PFA‐100® for assessing bleeding disorders and monitoring therapy: a review of analytical variables, benefits and limitations

    Article • Haemophilia, March 2001, Wiley

    Dr Emmanuel J Favaloro

  327. Possibility of potential VWD misdiagnosis or misclassification using LIA technology and due to presence of rheumatoid factor

    Article • American Journal of Hematology, January 2001, Wiley

    Dr Emmanuel J Favaloro

  328. Detection of von Willebrand Disorder and Identification of Qualitative von Willebrand Factor Defects Direct Comparison of Commercial ELISA-Based von Willebrand Factor Activity Options

    Article • American Journal of Clinical Pathology, October 2000, Oxford University Press (OUP)

    Dr Emmanuel J Favaloro

  329. Is the activity of VWF increased in type II diabetes mellitus?

    Article • Diabetes Research and Clinical Practice, September 2000, Elsevier

    Dr Emmanuel J Favaloro

  330. Sulfatide-Binding Assay for von Willebrand Factor

    Article • Thrombosis Research, April 2000, Elsevier

    Dr Emmanuel J Favaloro

  331. Type 2B von Willebrand's disease in thirteen individuals from five unrelated Australian families: Phenotype and genotype correlations

    Article • American Journal of Hematology, April 2000, Wiley

    Dr Emmanuel J Favaloro

  332. Possibility of potential VWD misdiagnosis or misclassification using LIA technology and due to presence of rheumatoid factor

    Article • American Journal of Hematology, January 2000, Wiley

    Dr Emmanuel J Favaloro

  333. Laboratory assessment as a critical component of the appropriate diagnosis and sub-classification of von Willebrand’s disease

    Article • Blood Reviews, December 1999, Elsevier

    Dr Emmanuel J Favaloro

  334. Use of a novel platelet function analyzer (PFA‐100™) with high sensitivity to disturbances in von willebrand factor to screen for von willebrand's disease and other disorders

    Article • American Journal of Hematology, November 1999, Wiley

    Dr Emmanuel J Favaloro

  335. Use of a novel platelet function analyzer (PFA-100?) with high sensitivity to disturbances in von willebrand factor to screen for von willebrand's disease and other disorders

    Article • American Journal of Hematology, November 1999, Wiley

    Dr Emmanuel J Favaloro

  336. Mesenteric vein thrombosis secondary to combined protein C deficiency and double heterozygosity for factor V leiden and prothrombin G20210A

    Article • American Journal of Hematology, November 1999, Wiley

    Dr Emmanuel J Favaloro

  337. Mesenteric vein thrombosis secondary to combined protein C deficiency and double heterozygosity for factor V leiden and prothrombin G20210A

    Article • American Journal of Hematology, November 1999, Wiley

    Dr Emmanuel J Favaloro

  338. Identification and characterization of a novel mutation in von Willebrand factor causing type 2B von Willebrand's disease

    Article • British Journal of Haematology, May 1999, Wiley

    Dr Emmanuel J Favaloro

  339. Clinical utility of anticardiolipin antibody assays: high inter-laboratory variation and limited consensus by participants of external quality assurance programs signals a cautious approach

    Article • Pathology, January 1999, Elsevier

    Dr Emmanuel J Favaloro

  340. Comparison of the effects of two low fat diets with different α-linolenic:linoleic acid ratios on coagulation and fibrinolysis

    Article • Atherosclerosis, January 1999, Elsevier

    Dr Emmanuel J Favaloro

  341. A Simple, Whole Blood Method for Assessment of Platelet Function

    Article • Thrombosis Research, May 1998, Elsevier

    Dr Emmanuel J Favaloro

  342. Biliary fibronectin: Significant limitation as a diagnostic tool in malignant biliary obstruction

    Article • Gastroenterology, April 1998, Elsevier

    Dr Emmanuel J Favaloro

  343. The MDA-180 coagulation analyser: a laboratory evaluation

    Article • Pathology, January 1997, Elsevier

    Dr Emmanuel J Favaloro

  344. Laboratory assays for von Willebrand Factor: relative contribution to the diagnosis of von Willebrand’s disease

    Article • Pathology, January 1997, Elsevier

    Dr Emmanuel J Favaloro

  345. Laboratory assessment of von Willebrand factor: differential influence of prolonged ambient temperature specimen storage on assay results

    Article • Haemophilia, October 1996, Wiley

    Dr Emmanuel J Favaloro

  346. Cardiovascular Risk Factors and Dietary Plant Omega-3 Verus Omega-6 Fatty Acids

    Article • Journal of the American Dietetic Association, September 1996, Elsevier

    Dr Emmanuel J Favaloro

  347. MUTATIONS IN A SUBGROUP OF PATIENTS WITH MILD HAEMOPHILIA A AND A FAMILIAL DISCREPANCY BETWEEN THE ONE‐STAGE AND TWO‐STAGE FACTOR VIII:C METHODS

    Article • British Journal of Haematology, August 1996, Wiley

    Dr Emmanuel J Favaloro

  348. A survey of heparin monitoring in australasia

    Article • Pathology, January 1996, Elsevier

    Dr Emmanuel J Favaloro

  349. Aminopeptidase-N (CD13; gp 150): Contrasting patterns of enzymatic activity in blood from patients with myeloid or lymphoid leukemia

    Article • Leukemia Research, September 1995, Elsevier

    Dr Emmanuel J Favaloro

  350. Attenuated platelet sensitivity to collagen in patients with neurofibromatosis type 1

    Article • British Journal of Haematology, March 1995, Wiley

    Dr Emmanuel J Favaloro

  351. von Willebrand's disease: Use of collagen binding assay provides potential improvement to laboratory monitoring of desmopressin (DDAVP) therapy

    Article • American Journal of Hematology, March 1994, Wiley

    Dr Emmanuel J Favaloro

  352. Differential expression of surface antigens on activated endothelium

    Article • Immunology and Cell Biology, December 1993, Wiley

    Dr Emmanuel J Favaloro

  353. The hepatobiliary disease marker serum alanine aminopeptidase predominantly comprises an isoform of the haematological myeloid differentiation antigen and leukaemia marker CD-13/gp150

    Article • Clinica Chimica Acta, October 1993, Elsevier

    Dr Emmanuel J Favaloro

  354. Acidified Chloroquine Treatment for the Removal of Class I HLA Antigens

    Article • Vox Sanguinis, July 1993, Wiley

    Dr Emmanuel J Favaloro

  355. Von willebrand's disease: laboratory investigation using an improved functional assay for von willebrand factor

    Article • Pathology, January 1993, Elsevier

    Dr Emmanuel J Favaloro

  356. Heparin - induced thrombocytopenia: laboratory investigation and confirmation of diagnosis

    Article • Pathology, January 1992, Elsevier

    Dr Emmanuel J Favaloro

  357. CD‐13 (‘gp150’; aminopeptidase‐N): Co‐expression on endothelial and haemopoietic cells with conservation of functional activity

    Article • Immunology and Cell Biology, August 1991, Wiley

    Dr Emmanuel J Favaloro

  358. Co‐expression of haemopoietic antigens on vascular endothelial cells: a detailed phenotypic analysis

    Article • British Journal of Haematology, April 1990, Wiley

    Dr Emmanuel J Favaloro

  359. Immunophenotype of clonogenic cells in myeloid leukaemia

    Article • Leukemia Research, January 1988, Elsevier

    Dr Emmanuel J Favaloro

  360. Coexpression of p165 myeloid surface antigen and terminal deoxynucleotidyl transferase: A comparison of acute myeloid leukaemia and normal bone marrow cells

    Article • American Journal of Hematology, September 1986, Wiley

    Dr Emmanuel J Favaloro

  361. Myeloid progenitor surface antigen identified by monoclonal antibody

    Article • British Journal of Haematology, September 1985, Wiley

    Dr Emmanuel J Favaloro

  362. Human myeloid differentiation antigens identified by monoclonal antibodies: expression on leukemic cells

    Article • Pathology, January 1985, Elsevier

    Dr Emmanuel J Favaloro